APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT

被引:129
|
作者
HUSSAIN, AS
YU, XQ
JOHNSON, RD
机构
[1] The Division of Pharmaceutics and Drug Delivery Systems, College of Pharmacy, University of Cincinnati-Medical Center, Cincinnati, Ohio
关键词
NEURAL COMPUTING; ARTIFICIAL NEURAL NETWORKS; PHARMACEUTICAL FORMULATION; RESPONSE SURFACE METHODOLOGY; CONTROLLED RELEASE; CAPSULES;
D O I
10.1023/A:1015843527138
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Neural computing technology is capable of solving problems involving complex pattern recognition. This technology is applied here to pharmaceutical product development. The most commonly used computational algorithm, the delta back-propagation network, was utilized to recognize the complex relationship between the formulation variables and the in vitro drug release parameters for a hydrophilic matrix capsule system. This new computational technique was also compared with the response surface methodology (RSM). Artificial neural network (ANN) analysis was able to predict the response values for a series of validation experiments more precisely than RSM. ANN may offer an alternative to RSM because it allows for the development of a system that can incorporate literature and experimental data to solve common problems in the pharmaceutical industry.
引用
收藏
页码:1248 / 1252
页数:5
相关论文
共 50 条
  • [41] Application of Trusted Computing in Automation to Prevent Product Piracy
    Lieberknecht, Nora
    TRUST AND TRUSTWORTHY COMPUTING, PROCEEDINGS, 2010, 6101 : 95 - 108
  • [42] ONTOLOGY SUPPORT FOR PRODUCT DEVELOPMENT Successful Application of Ontologies in Product Development
    Anderl, Reiner
    Mecke, Kai
    Sprenger, Andre
    Weitzmann, Oliver
    KEOD 2009: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON KNOWLEDGE ENGINEERING AND ONTOLOGY DEVELOPMENT, 2009, : 177 - 182
  • [43] Application of Multivariate Tools in Pharmaceutical Product Development to Bridge Risk Assessment to Continuous Verification in a Quality by Design Environment
    Zomer, Simeone
    Gupta, Manish
    Scott, Andy
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2010, 5 (03) : 109 - 118
  • [44] Application of Multivariate Tools in Pharmaceutical Product Development to Bridge Risk Assessment to Continuous Verification in a Quality by Design Environment
    Simeone Zomer
    Manish Gupta
    Andy Scott
    Journal of Pharmaceutical Innovation, 2010, 5 : 109 - 118
  • [45] Pharmaceutical business ecosystem governance and new product development success
    Pomegbe, Wisdom Wise Kwabla
    Dogbe, Courage Simon Kofi
    Borah, Prasad Siba
    INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2023, 72 (07) : 1942 - 1961
  • [46] New product development in the pharmaceutical and telecommunication industries: A comparative study
    Gupta, Abhishek
    Pawar, Kulwant S.
    Smart, Palie
    INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS, 2007, 106 (01) : 41 - 60
  • [47] A SHIFT TO EXTERNAL ALLIANCES FOR PRODUCT DEVELOPMENT IN THE PHARMACEUTICAL-INDUSTRY
    WHITTAKER, E
    BOWER, DJ
    R & D MANAGEMENT, 1994, 24 (03) : 249 - 260
  • [48] Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
    Quinlan, Judith
    Gaydos, Brenda
    Maca, Jeff
    Krams, Michael
    CLINICAL TRIALS, 2010, 7 (02) : 167 - 173
  • [49] Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development
    Brenda Gaydos
    Keaven M. Anderson
    Donald Berry
    Nancy Burnham
    Christy Chuang-Stein
    Jennifer Dudinak
    Parvin Fardipour
    Paul Gallo
    Sam Givens
    Roger Lewis
    Jeff Maca
    José Pinheiro
    Yili Pritchett
    Michael Krams
    Drug information journal : DIJ / Drug Information Association, 2009, 43 (5): : 539 - 556
  • [50] Pharmaceutical quality by design: Product and process development, understanding, and control
    Yu, Lawrence X.
    PHARMACEUTICAL RESEARCH, 2008, 25 (04) : 781 - 791